Product image of Metfogamma (Metformin Hydrochloride) supplied by GNH India

Metfogamma

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metfogamma (Metformin Hydrochloride)

Metformin, the active ingredient in Metfogamma, is a biguanide presented as an oral tablet for oral administration. It is used to improve glycemic control in adults with type 2 diabetes mellitus, helping to lower elevated blood glucose levels.

GNH India supplies Metfogamma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for regulated markets. The product complies with European Union pharmacopeial standards and undergoes rigorous quality testing before distribution, ensuring consistent potency and safety.

Manufacturer / TM Owner

Wörwag Pharma Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metfogamma (metformin) is used in the management of disorders related to impaired glucose metabolism.

  • Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels.
  • Prediabetes (impaired glucose tolerance): may delay progression to overt diabetes.
  • Polycystic ovary syndrome: can improve insulin resistance and help regulate menstrual cycles.

How It Works

  • Metfogamma acts by inhibiting hepatic gluconeogenesis and enhancing peripheral glucose uptake, primarily through activation of AMP‑activated protein kinase (AMPK). This results in reduced liver glucose output, increased insulin‑mediated glucose utilization in muscle, and decreased intestinal glucose absorption, collectively lowering blood glucose concentrations.

Side Effects

Metfogamma may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: frequent loose stools.
  • Abdominal discomfort: cramping or pain.
  • Metallic taste: persistent metallic sensation in the mouth.
  • Loss of appetite: reduced desire to eat.
  • Weight loss: modest reduction in body weight.

Serious or Rare Side Effects

  • Lactic acidosis: rare but potentially fatal metabolic disturbance.
  • Severe hypoglycemia: especially when combined with other glucose‑lowering agents.
  • Vitamin B12 deficiency: may develop with long‑term use.
  • Hepatic dysfunction: abnormal liver enzymes.
  • Skin rash: including severe reactions such as Stevens‑Johnson syndrome.
  • Pancreatitis: inflammation of the pancreas.

Precautions & Warnings

Metfogamma requires careful monitoring to ensure safe use.

  • Renal function assessment: evaluate kidney function before initiation and periodically thereafter.
  • Hepatic function monitoring: check liver enzymes in patients with liver disease.
  • Risk of lactic acidosis: avoid in patients with conditions predisposing to hypoxia.
  • Concomitant medication review: assess for drugs that may increase metformin levels.
  • Dose adjustment in elderly: consider lower starting doses for older adults.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Metfogamma can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate lactic acidosis; discontinue metformin before imaging.
  • Cimetidine: can increase metformin plasma concentrations.
  • Excessive alcohol intake: heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely)

  • Sulfonylureas or insulin: may enhance risk of hypoglycemia.
  • Beta‑blockers: can mask hypoglycemia symptoms.
  • ACE inhibitors or ARBs: may affect renal function, requiring dose adjustment.
  • Warfarin: may alter INR, necessitating closer monitoring.

Frequently Asked Questions

Metfogamma contains metformin, a biguanide antidiabetic that is indicated for the treatment of type 2 diabetes mellitus. It helps lower elevated blood glucose by improving the body’s response to insulin and reducing glucose production in the liver.

Metformin reduces hepatic glucose output and increases peripheral insulin sensitivity. It activates AMP‑activated protein kinase, which suppresses gluconeogenesis in the liver, enhances glucose uptake by muscle, and modestly decreases intestinal glucose absorption, leading to lower blood sugar levels.

The dose of Metfogamma is individualized by the prescribing clinician based on the patient’s clinical condition, renal function, and response to therapy. Typical starting doses are low and may be titrated upward, but exact amounts should follow the prescriber’s instructions.

Metfogamma’s pregnancy category is listed as unknown, and safety data are limited. It should only be used during pregnancy or lactation if the potential benefit justifies the potential risk, and the decision should be made by a qualified healthcare professional.

To order Metfogamma, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metfogamma (metformin) differs from sulfonylureas or insulin by not causing direct insulin release, which reduces the risk of hypoglycemia. Compared with newer agents such as SGLT2 inhibitors, metformin is generally less expensive and has a long safety record, though it may be less potent in some patients.

Metfogamma should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, heat and direct sunlight. Do not store in a bathroom or near a kitchen sink where humidity is high.

Metfogamma is taken orally, usually with a full glass of water. It can be taken with or without meals, but some patients find taking it with food reduces gastrointestinal discomfort. The tablet should be swallowed whole and not split or crushed unless specifically instructed by a healthcare provider.

The most serious adverse reactions to Metfogamma include lactic acidosis, a rare but potentially fatal condition, and severe hypoglycemia when combined with other glucose‑lowering agents. Long‑term use may also lead to vitamin B12 deficiency, which should be monitored periodically.

Metfogamma is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and known hypersensitivity to metformin. Caution is advised in individuals with hepatic disease, heart failure, or conditions that predispose to hypoxia.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT